Suppr超能文献

癌症中长链非编码RNA的转录谱分析及功能预测

Transcriptional profiling analysis and functional prediction of long noncoding RNAs in cancer.

作者信息

Yuan Jiao, Yue Haiyan, Zhang Meiying, Luo Jianjun, Liu Lihui, Wu Wei, Xiao Tengfei, Chen Xiaowei, Chen Xiaomin, Zhang Dongdong, Xing Rui, Tong Xin, Wu Nan, Zhao Jian, Lu Youyong, Guo Mingzhou, Chen Runsheng

机构信息

Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Beijing Key Laboratory of Noncoding RNA, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

出版信息

Oncotarget. 2016 Feb 16;7(7):8131-42. doi: 10.18632/oncotarget.6993.

Abstract

Long noncoding RNAs (lncRNAs), which are noncoding RNAs (ncRNAs) with length more than 200 nucleotides (nt), have been demonstrated to be involved in various types of cancer. Consequently, it has been frequently discussed that lncRNAs with aberrant expression in cancer serve as potential diagnostic biomarkers and therapeutic targets. However, one major challenge of developing cancer biomarkers is tumor heterogeneity which means that tumor cells show different cellular morphology, metastatic potential as well as gene expression. In this study, a custom designed microarray platform covering both mRNAs and lncRNAs was applied to tumor tissues of gastric, colon, liver and lung. 316 and 157 differentially expressed (DE-) protein coding genes and lncRNAs common to these four types of cancer were identified respectively. Besides, the functional roles of common DE-lncRNAs were inferred based on their expression and genomic position correlation with mRNAs. Moreover, mRNAs and lncRNAs with tissue specificity were also identified, suggesting their particular roles with regard to specific biogenesis and functions of different organs. Based on the large-scale survey of mRNAs and lncRNAs in four types of cancer, this study may offer new biomarkers common or specific for various types of cancer.

摘要

长链非编码RNA(lncRNA)是长度超过200个核苷酸(nt)的非编码RNA(ncRNA),已被证明与多种类型的癌症有关。因此,癌症中表达异常的lncRNA作为潜在的诊断生物标志物和治疗靶点这一话题经常被讨论。然而,开发癌症生物标志物的一个主要挑战是肿瘤异质性,这意味着肿瘤细胞表现出不同的细胞形态、转移潜能以及基因表达。在本研究中,一个定制设计的涵盖mRNA和lncRNA的微阵列平台被应用于胃、结肠、肝和肺的肿瘤组织。分别鉴定出这四种癌症共有的316个差异表达(DE-)蛋白质编码基因和157个lncRNA。此外,基于常见DE-lncRNA的表达及其与mRNA的基因组位置相关性推断了它们的功能作用。此外,还鉴定出了具有组织特异性的mRNA和lncRNA,表明它们在不同器官的特定生物发生和功能方面具有特殊作用。基于对四种癌症中mRNA和lncRNA的大规模调查,本研究可能会提供针对各种癌症的新的通用或特异性生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32bd/4884981/75bec2300138/oncotarget-07-8131-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验